Skip to main content

Table 1 Patient Characteristics

From: Quantified MRI and 25OH-VitD3 can be used as effective biomarkers for patients with neoadjuvant chemotherapy-induced liver injury in CRCLM?

Characteristic Value
General information
 Patient sex
  Male 22 (53.7%)
  Female 19 (46.3%)
 Mean age(y)* 54.4 ± 10.2 (32.0, 71.0)
 BMI (kg/m2)* 27.8 ± 4.3 (18.4, 33.1)
NC regimen
 FOLFOX 20 (48.7%)
 FOLFOX and cetuximab 4 (9.8%)
 FOLFIRI 13 (31.7%)
 FOLFIRI and bevacizumab 4 (9.8%)
CASH scores
 Grade 0 8 (19.5%)
 Grade 1 22 (53.7%)
 Grade 2 11 (26.8%)
 Grade 3
CASH scores
 Grade 0 10 (24.4%)
 Grade 1 23 (56.1%)
 Grade 2 8 (9.76%)
 Grade 3
CASH & SOS scores
 Grade 0 7 (17.1%)
 Grade 1 23 (56.1%)
 Grade 2 11 (26.8%)
 Grade 3  
  1. *Data are given as number (percentage) or mean ± standard deviation, with ranges in parentheses